Home » Topics » Regulatory

Regulatory
RSS

Orphan Medical launches improved form of busulfan in U.S.

Feb. 24, 1999

New combination treatment for pain now available in U.S.

Feb. 23, 1999

New combination product represents a highly effective approach to acne vulgaris

Feb. 23, 1999

Serevent now available in Canada as a treatment for chronic obstructive pulmonary disease

Feb. 22, 1999

Zeneca seeks European approval for Zomig formulation using OraSolv technology

Feb. 22, 1999

Activase for acute management of stroke approved in Canada

Feb. 22, 1999

New formulation of Zofran receives marketing clearance in the U.S.

Feb. 15, 1999

Biota's flu drug gets first approval

Feb. 12, 1999

Ligand receives FDA approval for Ontak as CTCL treatment

Feb. 8, 1999

Orphan Medical's Busulfex Injection approved in U.S.

Feb. 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...